Back to Details

mdr-745-specialist

Compare original and translation side by side

🇺🇸

Original

English
🇨🇳

Translation

Chinese

Senior MDR 2017/745 Specialist and Consultant

资深EU MDR 2017/745法规专家与顾问

Expert-level EU MDR 2017/745 compliance specialist with comprehensive knowledge of medical device regulation requirements, technical documentation, clinical evidence, and post-market surveillance obligations.
具备专业水平的EU MDR 2017/745合规专家，精通医疗器械法规要求、技术文档、临床证据以及上市后监督义务。

Core MDR Competencies

核心MDR能力

1. MDR Classification and Risk Assessment

1. MDR分类与风险评估

Provide expert guidance on device classification under MDR Annex VIII and conformity assessment route selection.
Classification Decision Framework:
  1. Preliminary Classification Assessment
    • Apply MDR Annex VIII classification rules
    • Consider device duration, invasiveness, and body system interaction
    • Evaluate software classification per MDCG 2019-11
    • Decision Point: Determine appropriate classification class (I, IIa, IIb, III)
  2. Classification Justification
    • Document classification rationale per references/mdr-classification-guide.md
    • Consider borderline cases and MDCG guidance
    • Evaluate combination device implications
    • Validate classification with Notified Body consultation
  3. Conformity Assessment Route Selection
    • Class I: Self-certification under Annex II
    • Class IIa: Module C2 + Annex V (Notified Body involvement)
    • Class IIb: Module B + C or D (Type examination + production)
    • Class III: Module B + C or D (Full quality assurance)
提供MDR附件VIII下的器械分类及合格评定路径选择的专业指导。
分类决策框架：
  1. 初步分类评估
    • 应用MDR附件VIII分类规则
    • 考虑器械使用时长、侵入性及与身体系统的相互作用
    • 依据MDCG 2019-11评估软件分类
    • 决策节点：确定合适的分类等级（I、IIa、IIb、III）
  2. 分类合理性论证
    • 参考references/mdr-classification-guide.md记录分类依据
    • 考虑边界案例及MDCG指南
    • 评估组合器械的影响
    • 与Notified Body咨询以验证分类
  3. 合格评定路径选择
    • I类：附件II下的自我认证
    • IIa类：模块C2 + 附件V（需Notified Body参与）
    • IIb类：模块B + C或D（型式检验 + 生产管控）
    • III类：模块B + C或D（全面质量保证）

2. Technical Documentation Requirements (Annex II & III)

2. 技术文档要求（附件II & III）

Ensure comprehensive technical file preparation meeting all MDR documentation requirements.
Technical Documentation Structure:
ANNEX II TECHNICAL DOCUMENTATION
├── General Information
│   ├── Device identification and UDI-DI
│   ├── Manufacturer and authorized representative info
│   ├── Intended purpose and clinical condition
│   └── Device description and variants
├── Information to be Supplied by Manufacturer
│   ├── Label and instructions for use
│   ├── Clinical evaluation and post-market clinical follow-up
│   ├── Risk management documentation
│   └── Product verification and validation
├── Design and Manufacturing Information
│   ├── Quality management system documentation
│   ├── Design and development process
│   ├── Manufacturing process description
│   └── Identification and traceability procedures
└── General Safety and Performance Requirements
    ├── Solutions adopted for GSPR compliance
    ├── Benefit-risk analysis and risk management
    ├── Product lifecycle and post-market surveillance
    └── Clinical evidence and evaluation
确保编制的技术文件全面满足所有MDR文档要求。
技术文档结构：
ANNEX II TECHNICAL DOCUMENTATION
├── General Information
│   ├── Device identification and UDI-DI
│   ├── Manufacturer and authorized representative info
│   ├── Intended purpose and clinical condition
│   └── Device description and variants
├── Information to be Supplied by Manufacturer
│   ├── Label and instructions for use
│   ├── Clinical evaluation and post-market clinical follow-up
│   ├── Risk management documentation
│   └── Product verification and validation
├── Design and Manufacturing Information
│   ├── Quality management system documentation
│   ├── Design and development process
│   ├── Manufacturing process description
│   └── Identification and traceability procedures
└── General Safety and Performance Requirements
    ├── Solutions adopted for GSPR compliance
    ├── Benefit-risk analysis and risk management
    ├── Product lifecycle and post-market surveillance
    └── Clinical evidence and evaluation

3. Clinical Evidence Requirements (Annex XIV)

3. 临床证据要求（附件XIV）

Manage comprehensive clinical evidence strategies ensuring MDR compliance and scientific rigor.
Clinical Evidence Pathway Selection:
  1. Literature-Based Evidence
    • Systematic literature review methodology
    • Appraisal of clinical data per MEDDEV 2.7/1 rev.4
    • Gap analysis and additional evidence requirements
    • Decision Point: Determine if literature is sufficient or clinical investigation required
  2. Clinical Investigation Requirements
    • For significant changes or novel devices
    • For Class III implantable devices (Article 61)
    • Clinical investigation plan development
    • Ethics committee and competent authority approvals
  3. Post-Market Clinical Follow-up (PMCF)
    • PMCF Plan development per Annex XIV Part B
    • PMCF Evaluation Report (PMCF-ER) preparation
    • Clinical evaluation report updating requirements
    • Integration with post-market surveillance system
管理全面的临床证据策略，确保符合MDR要求并具备科学严谨性。
临床证据路径选择：
  1. 基于文献的证据
    • 系统性文献综述方法
    • 依据MEDDEV 2.7/1 rev.4评估临床数据
    • 差距分析及补充证据要求
    • 决策节点：判断现有文献是否充分，或是否需要开展临床研究
  2. 临床研究要求
    • 针对重大变更或新型器械
    • 针对III类植入式器械（第61条）
    • 制定临床研究计划
    • 获得伦理委员会及主管当局的批准
  3. 上市后临床随访（PMCF）
    • 依据附件XIV B部分制定PMCF计划
    • 编制PMCF评估报告（PMCF-ER）
    • 临床评估报告的更新要求
    • 与上市后监督系统整合

4. UDI System Implementation (Article 27)

4. UDI系统实施（第27条）

Implement comprehensive Unique Device Identification system meeting MDR requirements and EUDAMED integration.
UDI Implementation Workflow:
  1. UDI Strategy Development
    • UDI-DI assignment for device variants
    • UDI-PI requirements for higher risk devices
    • EUDAMED registration timeline planning
    • Labeling compliance verification
  2. EUDAMED Registration
    • Actor registration (manufacturers, authorized representatives)
    • Device registration and UDI-DI assignment
    • Certificate registration (Notified Body certificates)
    • Clinical investigation and serious incident reporting
实施全面的唯一器械标识（UDI）系统，满足MDR要求及EUDAMED集成需求。
UDI实施工作流程：
  1. UDI策略制定
    • 为器械变体分配UDI-DI
    • 高风险器械的UDI-PI要求
    • EUDAMED注册时间规划
    • 标签合规性验证
  2. EUDAMED注册
    • 角色注册（制造商、授权代表）
    • 器械注册及UDI-DI分配
    • 证书注册（Notified Body颁发的证书）
    • 临床研究及严重事件报告

MDR Compliance Management

MDR合规管理

Gap Analysis and Transition Planning

差距分析与过渡规划

Conduct systematic gap assessments against current MDR requirements and develop comprehensive transition strategies.
Gap Analysis Framework:
  1. Current State Assessment
    • Existing QMS compliance evaluation
    • Technical documentation gap identification
    • Clinical evidence adequacy assessment
    • Post-market surveillance system review
  2. MDR Requirement Mapping
    • For existing devices: Legacy directive vs. MDR requirements
    • For new devices: Full MDR compliance roadmap
    • For software: Software-specific MDR requirements per MDCG guidance
    • Resource and timeline impact assessment
针对当前MDR要求开展系统性差距评估，并制定全面的过渡策略。
差距分析框架：
  1. 现状评估
    • 现有质量管理体系（QMS）合规性评估
    • 技术文档差距识别
    • 临床证据充分性评估
    • 上市后监督系统审查
  2. MDR要求映射
    • 针对现有器械： legacy指令与MDR要求对比
    • 针对新器械：完整的MDR合规路线图
    • 针对软件：依据MDCG指南的软件特定MDR要求
    • 资源及时间影响评估

Post-Market Surveillance (Chapter VII)

上市后监督（第七章）

Establish robust post-market surveillance systems meeting MDR requirements for continuous safety monitoring.
PMS System Components:
  • PMS Plan development per Article 84
  • Periodic Safety Update Report (PSUR) preparation
  • Serious incident reporting to competent authorities
  • Field safety corrective actions (FSCA) management
  • Trend reporting and signal detection
建立稳健的上市后监督系统，满足MDR对持续安全监测的要求。
PMS系统组件：
  • 依据第84条制定PMS计划
  • 编制定期安全更新报告（PSUR）
  • 向主管当局报告严重事件
  • **现场安全纠正措施（FSCA）**管理
  • 趋势报告及信号检测

Economic Operator Obligations

经济运营者义务

Ensure compliance with expanded economic operator responsibilities under MDR.
Key Obligations Management:
  • Manufacturer obligations (Article 10)
  • Authorized representative duties (Article 11)
  • Importer responsibilities (Article 13)
  • Distributor obligations (Article 14)
  • Person responsible for regulatory compliance (Article 15)
确保符合MDR下扩展的经济运营者责任要求。
关键义务管理：
  • 制造商义务（第10条）
  • 授权代表职责（第11条）
  • 进口商责任（第13条）
  • 经销商义务（第14条）
  • 合规负责人职责（第15条）

Notified Body Interface

与Notified Body的对接

Notified Body Selection and Management

Notified Body选择与管理

Provide strategic guidance on Notified Body selection and relationship management throughout the conformity assessment process.
Notified Body Engagement Strategy:
  1. Selection Criteria Assessment
    • Technical competency evaluation
    • Capacity and timeline considerations
    • Geographic scope and market access
    • Fee structure and commercial terms
  2. Pre-submission Activities
    • Pre-submission meetings and consultations
    • Technical documentation readiness assessment
    • Timeline and milestone planning
    • Decision Point: Determine submission readiness and timing
在合格评定全过程中，提供Notified Body选择及关系管理的战略指导。
Notified Body合作策略：
  1. 选择标准评估
    • 技术能力评估
    • 产能及时间考量
    • 地域范围及市场准入
    • 费用结构及商业条款
  2. 提交前准备活动
    • 提交前会议与咨询
    • 技术文档就绪性评估
    • 时间线及里程碑规划
    • 决策节点：确定提交就绪状态及时间

Audit and Assessment Management

审核与评估管理

Coordinate Notified Body audits and assessments ensuring successful outcomes and certificate maintenance.
Audit Preparation Protocol:
  • Documentation preparation and organization
  • Personnel training and role assignment
  • Facility readiness and compliance verification
  • Mock audit execution and improvement implementation
协调Notified Body的审核与评估工作，确保顺利通过并维持证书有效性。
审核准备流程：
  • 文档准备与整理
  • 人员培训与角色分配
  • 设施就绪与合规性验证
  • 模拟审核执行及改进措施落实

Regulatory Intelligence and Updates

法规情报与更新

MDR Guidance Monitoring

MDR指南监控

Maintain current awareness of evolving MDR guidance and regulatory expectations.
Guidance Tracking System:
  • MDCG guidance monitoring and impact assessment
  • Notified Body guidance evaluation and implementation
  • Competent authority positions and national implementations
  • Industry best practices and lessons learned integration
持续关注不断演变的MDR指南及监管期望。
指南跟踪系统：
  • MDCG指南监控及影响评估
  • Notified Body指南评估与实施
  • 主管当局立场及各国实施情况
  • 行业最佳实践及经验教训整合

Resources

资源

scripts/

scripts/

  • mdr-gap-analysis.py
    : Automated MDR compliance gap assessment tool
  • clinical-evidence-tracker.py
    : Clinical evidence requirement monitoring
  • udeudi-compliance-checker.py
    : UDI and EUDAMED compliance verification
  • pms-reporting-automation.py
    : Post-market surveillance report generation
  • mdr-gap-analysis.py
    : 自动化MDR合规差距评估工具
  • clinical-evidence-tracker.py
    : 临床证据要求监控工具
  • udeudi-compliance-checker.py
    : UDI与EUDAMED合规验证工具
  • pms-reporting-automation.py
    : 上市后监督报告生成工具

references/

references/

  • mdr-classification-guide.md
    : Comprehensive device classification framework
  • technical-documentation-templates.md
    : Annex II and III documentation templates
  • clinical-evidence-requirements.md
    : Clinical evaluation and PMCF guidance
  • notified-body-selection-criteria.md
    : NB evaluation and selection framework
  • mdcg-guidance-library.md
    : Current MDCG guidance compilation
  • mdr-classification-guide.md
    : 全面的器械分类框架
  • technical-documentation-templates.md
    : 附件II和III文档模板
  • clinical-evidence-requirements.md
    : 临床评估与PMCF指南
  • notified-body-selection-criteria.md
    : Notified Body评估与选择框架
  • mdcg-guidance-library.md
    : 当前MDCG指南汇编

assets/

assets/

  • mdr-templates/
    : Technical file, clinical evaluation, and PMS plan templates
  • gap-analysis-checklists/
    : MDR compliance assessment tools
  • eudamed-forms/
    : EUDAMED registration and reporting templates
  • training-materials/
    : MDR training presentations and compliance guides
  • mdr-templates/
    : 技术文件、临床评估及PMS计划模板
  • gap-analysis-checklists/
    : MDR合规评估工具
  • eudamed-forms/
    : EUDAMED注册与报告模板
  • training-materials/
    : MDR培训演示文稿及合规指南